News for hackers. Stuff that matters.
Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @01:28PM (#27986458)
Why not a policy of “vaccinated or recovered”? The data is pretty clear that the latter have ~~10x better immunity against reinfection. They also arguably provide better protection for the rest of us, since their natural immunity is less a monoculture.
Re:Vaccines and our return to office plans by Kaze404 on Wednesday July 28, 2021 @01:35PM (#27986606)
What data?
Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @02:01PM (#27987169)
All the data. Dataset after dataset. For example, 150K patients tracked by Israel: https://www.medrxiv.org/content/10.1101/2021.03.06.21253051v...
Re:Vaccines and our return to office plans by Kaze404 on Wednesday July 28, 2021 @03:31PM (#27988600)
> This article is a preprint and has not been peer-reviewed. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Re:Vaccines and our return to office plans by runawaybottle on Wednesday July 28, 2021 @01:31PM (#27986517)
That is my thought as well. If you had Covid, isn’t that the best vaccine you can get?
Re:Vaccines and our return to office plans by scott_s on Wednesday July 28, 2021 @01:32PM (#27986551)
Re:Vaccines and our return to office plans by throwaway3neu94 on Wednesday July 28, 2021 @01:39PM (#27986707)
In addition to all the points that article makes, two more:

1. There are a lot of people that believe they already had Covid, but actually didn't.

2. A "vaccinated or recovered" policy is even harder to enforce, as there are vaccination certificates but no recovery certificates. (Yes, vaccination certificates can be faked, but it seems likely to me that a significant part of the population would be willing to lie but not falsify documents.)

Re:Vaccines and our return to office plans by throwawayboise on Wednesday July 28, 2021 @01:46PM (#27986825)
There are tests for both presence of antibodies (quick and cheap, you can get one at many pharmacies or quick-care clinics) and T-cell immununity (IDK the cost or availabilty of those).
Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @02:04PM (#27987220)
She's lying. Notice how she links to no actual datasets.

On the contrary, all the big datasets show clearly a long lasting, low risk of reinfection for the recovered. Here, I include an actual dataset (https://www.medrxiv.org/content/10.1101/2021.03.06.21253051v...) unlike "Virologist Sabra Klein".

Re:Vaccines and our return to office plans by runawaybottle on Wednesday July 28, 2021 @02:34PM (#27987731)
Yeah, I personally just don’t get it. Your whole life you are told once you get the chicken pox, you won’t get it again. Once you get this year’s flu variant, you won’t get it again.

What is different about Coronavirus?

Re:Vaccines and our return to office plans by anyfoo on Wednesday July 28, 2021 @07:11PM (#27990939)
That sounds a bit simplistic. The common cold is also a viral disease, and people get it relatively frequently. AIDS is a viral disease with famously peculiar properties, constantly mutating and masquerading. Not all viral diseases are the same.
Re:Vaccines and our return to office plans by runawaybottle on Wednesday July 28, 2021 @07:57PM (#27991237)
So, again, theme of the day, have we not figured out the difference between aids, the flu, the cold, and the coronavirus? It feels like everyone is running from the truth here.
Re:Vaccines and our return to office plans by anyfoo on Wednesday July 28, 2021 @09:18PM (#27991726)
I'm not sure what you mean. Biology is incredibly complex. It would be hard/impossible to compress the "differences" into simple statements, I imagine.
Re:Vaccines and our return to office plans by runawaybottle on Wednesday July 28, 2021 @09:30PM (#27991811)
Is that true? We’ve classified a lot of things in life. The entire taxonomy of animals for example. No, I’m sorry, this is not beyond us. Where does Coronavirus fall? It’s not HIV, that’s for sure. Is it closer to the flu, or not?

I think we’re done playing this game as a society.

Re:Vaccines and our return to office plans by anyfoo on Thursday July 29, 2021 @12:15AM (#27992717)
Coronavirus is a kind of virus. Some of the many strains of the common cold are coronaviruses, so are COVID-19 and MERS. Flus are their own kind of virus, “influenza viruses”, but I only know what I know from quick conversations with actual biologists, so take it with a grain of salt. I don’t know whether taxonomy is necessarily helpful here. Some frogs are poisonous, some are delicacies, and they come in all sorts of colors, abilities, and sizes.
Re:Vaccines and our return to office plans by wombat-man on Wednesday July 28, 2021 @02:02PM (#27987186)
Antibodies from the vaccine are a lot more numerous and longer lasting in one's body. Apparently having had it only gives you a shorter duration of immunity.
Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @02:06PM (#27987259)
This is false. Data out of Israel now is that vaccine is ~40% effective (https://www.wsj.com/articles/pfizer-covid-19-vaccine-is-less...), while recovery is 99.9% effective (https://www.medrxiv.org/content/10.1101/2021.03.06.21253051v...).
Re:Vaccines and our return to office plans by Imnimo on Wednesday July 28, 2021 @02:48PM (#27987960)
These are not comparable quantities. The 99.9% is simply not an effectiveness rate, it's simply a raw calculation of how many recovered people were not reinfected over a time period. To convert that to an effectiveness rate, you would have to compare it to infection rate among unvaccinated & previously-uninfected people. This is what's being done in the 40% calculation.

Trying to compare these numbers is flat-out misinformation.

Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @04:31PM (#27989339)
The ballparks are indeed comparable, though I agree that I could have used numbers of a closer type.

A good back of the envelope guess is that if you've recovered from COVID odds are ~99.9% you won't get it again (for at least a year according to the data, more according to what we know about the immune system).

If you haven't had it but gotten the vaccine, odds are [infectionRate]*.6[andRising] that you will get it.

Or to put it another way, more vaccinated people in Israel tested positive for COVID just yesterday than all of the reinfections combined (~2K versus ~700).

I still think the vaccine is a good bet if you are over ~20 and haven't had COVID, but from the data I see natural immunity is going to be the main thing that gets us out of this pandemic, with vaccine the secondary factor.

Re:Vaccines and our return to office plans by Imnimo on Wednesday July 28, 2021 @04:47PM (#27989506)
>Or to put it another way, more vaccinated people in Israel tested positive for COVID just yesterday than all of the reinfections combined (~2K versus ~700).

Israel reported about 2K total positives yesterday. Are you trying to tell me that they were all vaccinated?

Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @05:14PM (#27989801)
I thought it was 2.6K, not 2K. In which cause I'd adjust my numbers to ~1.5K vaccinated tested positive yesterday. I left myself plenty of margin of safety for the conclusion however.

That's based on ~70% of hospitalized cases are vaccinated (https://datadashboard.health.gov.il/COVID-19/general). I don't read Hebrew and can't tell if they are reporting immunization status of cases as well as hospitalizations and I'm missing that, which is why I'm estimating. You'd expect the % of hospitalized patients to be less vaccinated (assuming vaccines lower serious cases), but also more vaccinated (since the elderly have higher vax rates).

For the ~700 I'm using the ~.1% x ~850K total infections.

Re:Vaccines and our return to office plans by Imnimo on Wednesday July 28, 2021 @05:45PM (#27990143)
This is not a good way to go about making a comparison.

First, hospitalized patients are a very different demographic than the population at large - you can't just hand-wave that away by saying that vaccination probably balances that out. A week ago, around 50% of infections were among vaccinated people, although this number has dropped significantly in the past week as the outbreak has reached communities with lower vaccination rates (ultra-orthodox, arab, etc.)

Second, you can't extrapolate reinfection rates studied pre-delta to today. We have seen in other places that delta presents a greater reinfection risk. In the UK, 1.2% of delta infections are among people who had previously recovered. That number is not directly comparable to Israel's 0.1%, because it's measuring a different thing, but it does not suggest a 99.9% protection given the UK's total number of cases (about a tenth of their population over the course of the entire pandemic).

I'm not saying that being previously infected doesn't offer strong protection. It clearly does. But you seem insistent on vastly overestimating the protection it offers while simultaneously underestimating the protection offered by vaccines. I think they're a lot closer than you're making them out to be.

Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @06:10PM (#27990412)
> In the UK, 1.2% of delta infections are among people who had previously recovered

This is very interesting. I hadn't seen that. Can you share a link?

Re:Vaccines and our return to office plans by Imnimo on Wednesday July 28, 2021 @06:13PM (#27990437)
https://web.archive.org/web/20210727002758/https://www.teleg...

(archive.org link to avoid paywall).

>Comparatively, some 1.2 per cent of the 83,197 delta cases analysed were in people who previously had the virus – one in 83.

Re:Vaccines and our return to office plans by breck on Wednesday July 28, 2021 @06:48PM (#27990750)
Still in the ballpark of 99%, but trending the wrong way. Something to keep an eye on. Thanks!
Re:Vaccines and our return to office plans by Imnimo on Wednesday July 28, 2021 @09:30PM (#27991808)
But as I said, these are not comparable quantities. 99.9% is the percentage of previously-infected people in Israel who were re-infected. This 99% is the percentage of infections which are reinfections. It's a totally different number.

If we were to naively calculate an "effectiveness" from this data point (which I absolutely do not think we should do), it'd go like this: First, about 10% of the UK population has been infected. If there were no protection for re-infected people, we'd, of course, expect 10% of cases to be re-infections. Instead it's more like 1%, which suggests that being previously infected makes you 10x less likely to be infected. This gives a 90% back-of-the-envelope "effectiveness" against reinfection.

Now, I don't think it's actually 90% - I think that analysis leaves out a lot of other information we'd need to know. And besides, we'd have to perform a similar conversion for the Israeli 99.9% number to have something to compare to. But we shouldn't make the mistake of saying "99.9% and 99% are in the same ballpark".